Whereas previous studies have shown that MAdCAM-1 is more frequently found in PSC patients compared to controls [[13], [14], [15]], we now showed that the extent of tissue expressing MAdCAM-1 is much larger in PSC liver compared to control liver. This evidence concerns the gene MADCAM1 and pancreatic serous cystadenoma.